Author Correction: Sex differences of fall-risk-increasing drugs in the middle-aged and elderly: a descriptive, cross-sectional study of FDA adverse event reporting system

Author Correction: Sex differences of fall-risk-increasing drugs in the middle-aged and elderly: a descriptive, cross-sectional study of FDA adverse event reporting system

Saved in:

Bibliographic Details
Main Authors:	Ying Zhao, Yuke Zhong, Liuqing Wu, Jiao Yan, Weitao Lu
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-025-88803-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sex differences of fall-risk-increasing drugs in the middle-aged and elderly: a descriptive, cross-sectional study of FDA adverse event reporting system
by: Ying Zhao, et al.
Published: (2024-11-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022-01-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
by: Shuai Zhao, et al.
Published: (2025-02-01)

Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
by: Weidong Zhang, et al.
Published: (2025-01-01)

A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
by: Ke He, et al.
Published: (2025-01-01)

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
by: Wenchao Lu, et al.
Published: (2025-01-01)

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database
by: Yalan Tian, et al.
Published: (2025-01-01)

The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Yue Zhou, et al.
Published: (2025-01-01)

Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01)

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database
by: Qun Li, et al.
Published: (2025-02-01)

Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Lisi Xu, et al.
Published: (2025-01-01)

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01)

Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database
by: Hunong Xiang, et al.
Published: (2025-01-01)

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system
by: Yixuan Yang, et al.
Published: (2025-01-01)

Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System
by: Yang Hu, et al.
Published: (2020-01-01)

Author Correction: Sex differences in the association between repetitive negative thinking and neurofilament light
by: Yolanda Lau, et al.
Published: (2025-01-01)

Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
by: Zhaohui Li, et al.
Published: (2024-11-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Detection Performance Analysis of the Standard FDA and FDA-MIMO Radar in the Gaussian Background
by: Yongze Liu, et al.
Published: (2021-01-01)

Correlates of Falls among Community-Dwelling Elderly in Thailand
by: Titaporn Worapanwisit, et al.
Published: (2018-01-01)

Mediterranean Diet Mediates the Adverse Effect of Depressive Symptomatology on Short-Term Outcome in Elderly Survivors from an Acute Coronary Event
by: Christina Chrysohoou, et al.
Published: (2011-01-01)

Author Correction: Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose
by: Nao Iguchi, et al.
Published: (2025-02-01)

Author Correction: Considerations in the search for epistasis
by: Marleen Balvert, et al.
Published: (2025-01-01)

Fear of Falling among Elderly Individuals with Various Medical Conditions
by: T.K. Konovalchik
Published: (2025-01-01)

Hobbit: Providing Fall Detection and Prevention for the Elderly in the Real World
by: Markus Bajones, et al.
Published: (2018-01-01)

Adverse events of hepatic anti-fibrotic agents in phase 3 and above clinical trials: a descriptive analysis of the WHO-VigiAccess database
by: Yuwei Liu, et al.
Published: (2025-01-01)

Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure
by: Zhiyong Li, et al.
Published: (2022-01-01)

Author Correction: The Maddaloni/X-6 eruption stands out as one of the major events during the Late Pleistocene at Campi Flegrei
by: Giada Fernandez, et al.
Published: (2025-02-01)

Falling sex ratios and emerging evidence of sex-selective abortion in Nepal: evidence from nationally representative survey data
by: Mahesh Puri, et al.
Published: (2013-05-01)

Falls and Fractures in the Elderly with Sinus Node Disease: The Impact of Pacemaker Implantation
by: Nazmi Krasniqi, et al.
Published: (2012-01-01)

FDA-MIMO Beampattern Synthesis with an Analytical Method
by: Changlin Zhou, et al.
Published: (2021-01-01)

Author Correction: The struggle at the International Seabed Authority over deep sea mineral resources
by: Isabel Feichtner, et al.
Published: (2025-01-01)

Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
by: Heiko Koerner, et al.
Published: (2012-01-01)

Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
by: Gian Lima, et al.
Published: (2019-01-01)

Rates of Minor Adverse Events and Health Resource Utilization Postcolonoscopy
by: Vladimir Marquez Azalgara, et al.
Published: (2014-01-01)

Scanning and vicarious learning from adverse events in health care
Published: (2001-01-01)